First Patient Treated in LeAAPS Clinical Trial
Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
The EnCompass® Clamp is the newest innovation in bipolar RF ablation. EnCompass provides a magnetic guide, parallel closure, and uniform tissue pressure – while harnessing the technology we know works well.
The EnCompass® Clamp is the newest innovation in bipolar RF ablation. EnCompass provides a magnetic guide, parallel closure, and uniform tissue pressure – while harnessing the technology we know works well.
We're grateful for the skilled #SurgicalTechs who ensure safe and smooth operating rooms each day. Thank you for all you do! #SurgicalTechWeek
We're grateful for the skilled #SurgicalTechs who ensure safe and smooth operating rooms each day. Thank you for all you do! #SurgicalTechWeek
Do you have patients with inappropriate sinus tachycardia (IST)? If they’ve become refractory or intolerant to medications, they may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist
Do you have patients with inappropriate sinus tachycardia (IST)? If they’ve become refractory or intolerant to medications, they may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist
A metanalysis of CONVERGE and Real-World Data showed a 30-day major adverse event rate of 4% with a 95% confidence interval of 3-6% among more than 1,100 Hybrid Convergent Patients studied. See more #HybridAFTherapy data at https://bit.ly/47WQBk8
A metanalysis of CONVERGE and Real-World Data showed a 30-day major adverse event rate of 4% with a 95% confidence interval of 3-6% among more than 1,100 Hybrid Convergent Patients studied. See more #HybridAFTherapy data at https://bit.ly/47WQBk8
social media channels to keep updated on the latest at AtriCure.